Future Market Insights opines the lipids market is bifurcating between a high-growth precision lipid segment driven by lipid nanoparticle manufacturing for mRNA therapeutics and nucleic acid drug delivery systems, and a volume-driven commodity oilseed processing segment navigating crush margin compression and biofuel policy uncertainty, with the two trajectories requiring fundamentally different capital allocation and customer relationship strategies from suppliers positioned across both.